Le Lézard
Classified in: Health
Subject: SVY

Global Drug Discovery Outsourcing Market Analysis Report 2018



DUBLIN, Aug 14, 2018 /PRNewswire/ --

The "Drug Discovery Outsourcing Market Analysis Report By Workflow (Lead Identification & Candidate Optimization, Preclinical Development), By Therapeutic Area, By Drug Type, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global drug discovery outsourcing market size is expected to reach USD 4.44 billion by 2025 at an 8.14% CAGR

Urging need to identify potential drug candidates for various chronic diseases is anticipated to fuel growth.

Technological advances in in silico drug designing and accelerating integration of Artificial Intelligence (AI) in drug discovery are driving industry progress. Multiple applications of AI algorithms in drug design and discovery provide opportunities for players to offer specialized drug discovery services. It is useful for processes such as target and compound selection, predictive analytics, screening, and drug repurposing.

Projected rise in adoption of outsourcing over the forecast period is expected to boost market revenue generation. Half of the drug discovery processes are anticipated to be outsourced, thereby creating massive opportunities for CROs, CMOs, and CDMOs to expand their market presence.

Number of collaborations among these organizations, key pharmaceutical players, and several universities has increased over the past few years. This rise in alliance further supports the projected increase in growth potential.

High cost and high risk of drug failure are major challenges faced in drug discovery. However, advances in technology that increase efficiency of drug discovery, coupled with increased adoption of highly advanced technology to provide specialized services, allow outsourcing companies to overcome these challenges.


Further key findings from the report suggest:

Key Topics Covered:

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Drug Discovery Outsourcing Market: Variables, Trends & Scope
3.1 Market Segmentation &Scope
3.1.1 Market driver analysis
3.1.1.1 Increasing trends of partnerships in drug discovery research
3.1.1.2 Rising incidence rate of metabolic, genetic and other chronic diseases
3.1.1.3 Technology advancement in drug discovery
3.1.2 Market restraint analysis
3.1.2.1 High cost and high risk of drug failure
3.2 Penetration &Growth Prospect Mapping for Workflow, 2016
3.3 Drug Discovery Outsourcing - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.4 Industry Analysis - Porter's

Chapter 4 Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis
4.1 Global Drug Discovery Outsourcing Market: Workflow Movement Analysis
4.2 Target Identification & Screening
4.3 Target Validation & Functional Informatics
4.4 Lead Identification & Candidate Optimization
4.5 Preclinical Development
4.6 Other Associated Workflow

Chapter 5 Drug Discovery Outsourcing Market: Therapeutic Area Estimates & Trend Analysis
5.1 Global Drug Discovery Outsourcing Market: Therapeutic Area Movement Analysis
5.2 Respiratory System Disorders
5.3 Pain and Anesthesia
5.4 Oncology Disorders
5.5 Ophthalmology Disorders
5.6 Hematology Disorders
5.7 Cardiovascular Disorders
5.8 Endocrine Disorders
5.9 Gastrointestinal Disorders
5.10 Immunomodulation Disorders
5.11 Anti-Infective
5.12 Central Nervous System Disorders
5.13 Dermatology Disorders
5.14 Genitourinary System Disorders

Chapter 6 Drug Discovery Outsourcing Market: Drug Type Estimates & Trend Analysis
6.1 Global Drug Discovery Outsourcing Market: Drug Type Movement Analysis
6.2 Small Molecules
6.3 Large Molecules

Chapter 7 Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis by Workflow, Therapeutic Area, & Drug Type

Chapter 8 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/7958vz/global_drug?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



SOURCE Research and Markets


These press releases may also interest you

at 17:03
PRA Health Sciences, Inc. will release its third quarter results after the market closes on Wednesday, October 31, 2018. The Company will also host a conference call on Thursday, November 1, 2018 at 9:00 a.m. (ET) to discuss the results with members...

at 17:00
VISTA, Calif., Sept. 25, 2018 /PRNewswire-PRWeb/ -- Internationally recognized upper cervical chiropractic practice strategist and speaker, Dr. Bill Davis has launched an empowering new book titled, Upper Cervical Practice Mastery. After three long...

at 17:00
Leading research scientists will present the latest in arthritis prevention and treatment at Arthritis Research Canada's annual Reaching Out with Arthritis Research public forum on September 29.   PRESENTERS AND TOPICS...

at 17:00
Nxt-ID, Inc.  a provider of healthcare devices as well as payment, credential management, and authentication platform services, announces its management team will host an investor webcast to discuss the recently announced plan to spin-off its payment...

at 16:59
BRUSTIN & LUNDBLAD, LTD. won a jury verdict in the amount of $18,500,000.00 on behalf of a 12-year old boy who was injured by the prescription of a mental health drug to his mother when he was in the fetal stage.  In addition, it was alleged that the...

at 16:53
Healogics Inc., the nation's largest provider of advanced wound care services, today announced they have joined the App Orchard to begin working on an integration to improve interoperability within their nationwide network of Wound Care Centers®....




News published on 14 august 2018 at 15:00 and distributed by: